Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
All content for Cleveland Clinic Cancer Advances is the property of Cleveland Clinic Taussig Cancer Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
Personalizing Treatment of Myelofibrosis-Associated Anemia
Cleveland Clinic Cancer Advances
20 minutes
4 months ago
Personalizing Treatment of Myelofibrosis-Associated Anemia
Akriti Jain, MD, a Hematologist and Medical Oncologist specializing in leukemia and myeloid disorders at Cleveland Clinic, joins the Cancer Advances Podcast to discuss personalizing treatment approaches for myelofibrosis-associated anemia. Listen as Dr. Jain provides insights into the evolving therapeutic landscape, explaining how the field has expanded beyond single-agent therapy.
Cleveland Clinic Cancer Advances
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
